Pharmacological MRI (phMRI) Monitoring of Treatment in Hemiparkinsonian Rhesus Monkeys
There is a great need for the development of noninvasive, highly sensitive, and widely available imaging methods that can potentially be used to longitudinally monitor treatment of Parkinson's disease (PD). Here we report the monitoring of GDNF-induced functional changes of the basal ganglia in...
Main Authors: | Liming Luan, Feng Ding, Yi Ai, Anders Andersen, Peter Hardy, Eric Forman, Greg A. Gerhardt, Don M. Gash, Richard Grondin, Zhiming Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-04-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368908784423319 |
Similar Items
-
Validations of apomorphine-induced BOLD activation correlations in hemiparkinsonian rhesus macaques
by: J.E. Quintero, et al.
Published: (2019-01-01) -
phMRI: methodological considerations for mitigating potential confounding factors
by: Julius H Bourke, et al.
Published: (2015-05-01) -
Single subject pharmacological-MRI (phMRI) study: Modulation of brain activity of psoriatic arthritis pain by cyclooxygenase-2 inhibitor
by: Chialvo DR, et al.
Published: (2005-11-01) -
Intranigral Transplantation of Fetal Substantia Nigra Allograft in the Hemiparkinsonian Rhesus Monkey
by: Philip A. Starr M.D.,Ph.D., et al.
Published: (1999-01-01) -
Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate.
by: Anouk Schrantee, et al.
Published: (2017-01-01)